🔎 Trials Near Me

Home › Immunoglobulin Light-chain Amyloidosis › Arizona

Immunoglobulin Light-chain Amyloidosis clinical trials in Arizona

3 studies for Immunoglobulin Light-chain Amyloidosis are looking for participants at sites in Arizona.

Daratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial

  • Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05898646

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

  • Research Site, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT07081646

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

  • CTCA at Western Regional Medical Center, Goodyear
  • Banner University Medical Center - Tucson, Tucson
  • University of Arizona Cancer Center-North Campus, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06022939

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.